Benzinga - by Benzinga Insights, Benzinga Staff Writer.
A substantial insider activity was disclosed on February 1, as Slater, VP & CFO at Olin (NYSE:OLN), reported the exercise of a large sell of company stock options.
What Happened: A notable Form 4 filing on Thursday with the U.S. Securities and Exchange Commission revealed that Slater, VP & CFO at Olin, exercised stock options for 63,250 shares of OLN, resulting in a transaction value of $1,572,847.
During Thursday's morning session, Olin shares down by 0.0%, currently priced at $52.07. Considering the current price, Slater's 63,250 shares have a total value of $1,572,847.
Get to Know Olin Better Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.
Understanding the Numbers: Olin's Finances Negative Revenue Trend: Examining Olin's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -3.4% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Insights into Profitability:
- Gross Margin: The company issues a cost efficiency warning with a low gross margin of 11.38%, indicating potential difficulties in maintaining profitability compared to its peers.
- Earnings per Share (EPS): Olin's EPS reflects a decline, falling below the industry average with a current EPS of 0.44.
Understanding Financial Valuation:
- Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 14.59 is lower than the industry average, indicating potential undervaluation for the stock.
- Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 0.98 as compared to the industry average, the stock might be considered overvalued based on sales performance.
- EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Olin's EV/EBITDA ratio, surpassing industry averages at 7.15, positions it with an above-average valuation in the market.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Impact of Insider Transactions on Investments Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
A Deep Dive into Insider Transaction Codes When it comes to transactions, investors tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Olin's Insider Trades.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.